A

AixThera

Europe, Dublin, Ireland, Dublin

Description

AixThera was formed to invest in the development of new therapeutics with the potential to positively impact patient lives.

Investor Profile

AixThera has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series A rounds (top funding stages).
  • Majority of deals are located in United Kingdom.
  • Strong thematic focus on Biopharma, Biotechnology, Health Care.

Stage Focus

  • Series A (100%)

Country Focus

  • United Kingdom (100%)

Industry Focus

  • Biopharma
  • Biotechnology
  • Health Care
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does AixThera frequently co-invest with?

BACKED VC
Europe, England, United Kingdom, London
Co-Investments: 1
H
Asia, T'ai-wan, Taiwan, Hsinchu
Co-Investments: 1
EIT Health
Europe, Bayern, Germany, Munich
Co-Investments: 1
Lifeforce Capital
North America, California, United States, San Francisco
Co-Investments: 1
Selvedge Venture
Europe, England, United Kingdom, London
Co-Investments: 1
LifeLink Ventures
Europe, Catalonia, Spain, Barcelona
Co-Investments: 1
Khosla Ventures
North America, California, United States, Menlo Park
Co-Investments: 1

Which angels does AixThera often collaborate with?

AZ
North America, California, United States, San Francisco
Shared Deals: 1
KF
North America, California, United States, San Francisco
Shared Deals: 1
MC
North America, New York, United States, New York
Shared Deals: 1

What are some of recent deals done by AixThera?

Ochre Bio

Oxford, Oxfordshire, United Kingdom

Ochre Bio is a biotechnology company that develops and builds a deep phenotyping platform to rejuvenate transplant livers.

BiopharmaBiotechnologyHealth CareTherapeutics
Series AOct 10, 2022
Amount Raised: $30,000,000